FOR RESEARCH USE ONLY. The content provided in this article is for educational and informational purposes only and is based on published scientific literature. The compounds discussed are not approved by the FDA for human or veterinary use. They are strictly intended for laboratory research and in vitro experimentation. Pure Health Peptides does not endorse or encourage the use of these products outside of a controlled research setting.
Mechano Growth Factor, abbreviated MGF, is a research peptide derived from a splice variant of insulin-like growth factor 1 (IGF-1). It is studied for a specific piece of muscle-signaling biology: the way mechanical loading of muscle tissue prompts the body to produce an alternative form of IGF-1, and the distinctive C-terminal segment, the E-domain, that this variant carries. That E-domain is what makes MGF a separate research subject from ordinary IGF-1.
This article describes what Mechano Growth Factor is, the E-domain and satellite-cell research behind it, how MGF relates to its pegylated sibling PEG-MGF, and how the material is verified as research-grade.
Research Snapshot
- Mechano Growth Factor (MGF) is a splice variant of IGF-1, formally IGF-1Ec, generated in muscle tissue in response to mechanical loading and damage. It differs from systemic IGF-1 by its unique C-terminal E-domain.
- The research interest centers on the MGF E-domain peptide, a short C-terminal sequence that appears to act separately from the mature IGF-1 portion of the molecule. Because “MGF” can refer either to the full IGF-1Ec protein or to the isolated E-domain peptide, a single fixed molecular formula is not universally applicable.
- In preclinical and in vitro research, MGF and its E-domain have been studied for a reported role in activating muscle satellite cells, the resident precursor cells involved in muscle-tissue research (Yang & Goldspink, 2002; Ates et al., 2011).
- PEG-MGF is a pegylated form of the E-domain peptide (published sequence PEG-YQPPSTNKNTKSQRRKGSTFEERK), where a polyethylene glycol group is added to extend the peptide’s stability in solution relative to the unmodified peptide.
- Pure Health Peptides supplies MGF as a lyophilized Vial and PEG-MGF as a separate Vial, both part of the wider catalog. Every lot is finished and tested in the USA, routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics as the exclusive testing partner.
Introduction
Mechano Growth Factor sits inside one of the more specific stories in growth-factor biology. Insulin-like growth factor 1 is a well-studied signaling protein, but the gene that encodes it can be spliced in more than one way.
When muscle tissue is mechanically loaded or damaged, the tissue produces an alternative splice variant, IGF-1Ec, and that variant is what researchers named Mechano Growth Factor. Its defining feature is a distinct C-terminal segment, the E-domain, that the standard circulating form of IGF-1 does not carry in the same way.
That single structural difference is the reason MGF is studied as its own research subject. This article stays with that mechanism and the preclinical research built on it: the splice-variant origin, the E-domain peptide, the satellite-cell signaling research, and the relationship between MGF and the pegylated PEG-MGF. It describes findings in rodent and in vitro systems and holds to research-use framing throughout.
What Mechano Growth Factor Is: An IGF-1 Splice Variant
Mechano Growth Factor is not a wholly separate molecule from IGF-1. It is a splice variant of the same gene, formally designated IGF-1Ec. The IGF-1 gene can be transcribed and spliced into different isoforms, and the isoform that predominates in mechanically loaded muscle carries a different C-terminal extension, the E-domain, from the systemic isoform.
Because of that splice-variant origin, the name “MGF” is used in the literature in two overlapping ways. It can refer to the full IGF-1Ec protein, which includes both the mature IGF-1 region and the E-domain, or it can refer specifically to the isolated E-domain peptide that is synthesized and studied on its own. This is why a single fixed molecular formula is not universally applicable to “MGF”: the term covers a full splice-variant protein and a short synthetic peptide derived from its tail. The research peptide most commonly supplied and studied under the MGF label is the E-domain sequence.
The E-Domain and Satellite Cell Research
The E-domain is where most of the distinct research interest lies. The observation that drives it is that the E-domain segment appears to have activity of its own, separate from the mature IGF-1 portion of the molecule, in the preclinical models that have examined it. In particular, research has focused on muscle satellite cells, the resident precursor cells that participate in muscle-tissue maintenance and research models of tissue turnover.
The literature reports that MGF and its E-domain can influence the activation and proliferation of these satellite cells in vitro and in rodent studies (Yang & Goldspink, 2002; Ates et al., 2011), and later work examined the E-domain’s signaling behavior and its distinct kinetics relative to mature IGF-1 (Philippou et al., 2013).
The picture is not uniform: at least one study reported that a synthetic E-domain peptide did not show the proposed independent activity under its conditions (Fornaro et al., 2014), which is a useful reminder that the mechanism remains an active and unsettled area of preclinical research rather than a closed question. Taken together, that body of work is exactly why MGF is studied as a defined tool for probing the muscle-loading response, always in the preclinical and in vitro terms the literature uses.
MGF and PEG-MGF: The Pegylated Form
A practical limitation of the unmodified E-domain peptide is stability. Short peptides in solution can degrade relatively quickly, which complicates research handling. PEG-MGF is the response to that: it is the E-domain peptide with a polyethylene glycol (PEG) group attached, a modification known as pegylation. Pure Health Peptides publishes the PEG-MGF sequence as PEG-YQPPSTNKNTKSQRRKGSTFEERK.
Pegylation is a well-established technique for improving a peptide’s stability profile in solution, and in the catalog PEG-MGF is offered as a separate research vial alongside the unmodified MGF vial. For researchers, the two are distinct tools: the unmodified E-domain peptide and its more stable pegylated counterpart, chosen according to the experiment. Both are supplied as lyophilized vials and verified through the same chain.
Verification
Underneath both peptides is the verification chain. Pure Health Peptides does not manufacture the material; production is sourced from qualified third-party manufacturers, and the material is finished and tested in the USA. Every lot is routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics as the exclusive testing partner, and each qualified lot’s Certificate of Analysis is published in the COA Library, in the vial section, retrievable by batch ID.
For a lyophilized vialed peptide the appropriate panel extends beyond identity, purity, and quantity to include endotoxin and microbial limits, because contamination can enter downstream of synthesis through handling, lyophilization, vial filling, storage, and transit.
The Testing Process page documents how that verification runs, and the Manufacturing Process page covers where the material comes from.
Where MGF Sits in Muscle-Signaling Research
For researchers studying the IGF-1 axis and the muscle response to mechanical loading, Mechano Growth Factor is a specific and well-defined tool: a splice-variant-derived peptide whose distinct E-domain is the object of study. Its research value rests on that origin, an alternative IGF-1 isoform produced by loaded muscle, and on the open questions that still surround how the E-domain signals on its own.
As research on IGF-1 splice variants and satellite-cell biology continues, MGF and its pegylated form remain useful reference tools, and the two hold a clear place in the muscle-signaling corner of the catalog.
Frequently Asked Questions
What is MGF (Mechano Growth Factor)?
MGF is a research peptide derived from IGF-1Ec, a splice variant of insulin-like growth factor 1 that is produced in muscle tissue in response to mechanical loading. It is distinguished by its unique C-terminal E-domain.
How is MGF different from IGF-1?
MGF is a splice variant of the same IGF-1 gene, not a separate molecule. It carries a distinct C-terminal E-domain that the standard systemic form of IGF-1 does not, and that E-domain is the focus of most MGF research.
What is MGF studied for in research?
It is studied in preclinical and in vitro models for the reported role of its E-domain in activating and proliferating muscle satellite cells. Findings are mixed, and the independent activity of the E-domain remains an active research question.
What is the difference between MGF and PEG-MGF?
PEG-MGF is the E-domain peptide with a polyethylene glycol group attached (pegylation), a modification used to improve the peptide’s stability in solution. Pure Health Peptides supplies MGF and PEG-MGF as separate research vials.
What carrier format is MGF available in, and how is it verified?
A lyophilized vial. Every lot is finished and tested in the USA and routed through independent, ISO/IEC 17025-accredited testing by Ethos Analytics, with a lot-specific Certificate of Analysis published in the COA Library.
References
- Yang SY, Goldspink G. Different roles of the IGF-1Ec peptide (MGF) and mature IGF-1 in myoblast proliferation and differentiation. FEBS Letters, 2002;522(1-3):156-160. https://doi.org/10.1016/S0014-5793(02)02918-6
- Ates K, et al. The IGF-1 splice variant MGF and its E-domain peptide in skeletal muscle. 2011. https://pubmed.ncbi.nlm.nih.gov/21354439/
- Philippou A, et al. Expression of IGF-1 isoforms and the MGF E-domain peptide in muscle signaling research. PLoS One, 2013. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795771/
- Fornaro M, et al. Mechano-growth factor peptide, the C-terminal E-domain of IGF-1Ec, evaluated for independent activity. American Journal of Physiology – Endocrinology and Metabolism, 2014. https://doi.org/10.1152/ajpendo.00408.2013
- International Organization for Standardization / International Electrotechnical Commission. ISO/IEC 17025:2017, General requirements for the competence of testing and calibration laboratories. https://www.iso.org/standard/66912.html
